Does TOFACITINIB Cause Terminal state? 92 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 92 reports of Terminal state have been filed in association with TOFACITINIB (XELJANZ XR). This represents 0.1% of all adverse event reports for TOFACITINIB.
92
Reports of Terminal state with TOFACITINIB
0.1%
of all TOFACITINIB reports
45
Deaths
70
Hospitalizations
How Dangerous Is Terminal state From TOFACITINIB?
Of the 92 reports, 45 (48.9%) resulted in death, 70 (76.1%) required hospitalization, and 82 (89.1%) were considered life-threatening.
Is Terminal state Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TOFACITINIB. However, 92 reports have been filed with the FAERS database.
What Other Side Effects Does TOFACITINIB Cause?
Drug ineffective (30,382)
Pain (21,659)
Condition aggravated (16,925)
Arthralgia (15,640)
Fatigue (13,551)
Rheumatoid arthritis (12,277)
Off label use (11,736)
Headache (11,061)
Joint swelling (10,686)
Malaise (9,040)
What Other Drugs Cause Terminal state?
LEUPROLIDE (700)
DENOSUMAB (563)
DARBEPOETIN ALFA (299)
CARBIDOPA\LEVODOPA (289)
ADALIMUMAB (253)
OCTREOTIDE (232)
ETANERCEPT (200)
RITUXIMAB (182)
ABATACEPT (181)
CLOZAPINE (180)
Which TOFACITINIB Alternatives Have Lower Terminal state Risk?
TOFACITINIB vs TOFERSEN
TOFACITINIB vs TOLNAFTATE
TOFACITINIB vs TOLODODEKIN ALFA
TOFACITINIB vs TOLTERODINE
TOFACITINIB vs TOLVAPTAN